Key result
Cardiac pacing therapy indications have expanded since 1958 to include sinus node dysfunction, atrial tachyarrhythmias, and heart failure with cardiac dyssynchrony.
A historical overview of the evolution and expanding indications for cardiac pacing device implantation.
Guides contemporary pacing decisions across expanded indications; leaves open prospective validation of newer applications.
The history of cardiac pacing device implantation began in 1958, when Seymour Furman utilised temporary transvenous pacing as therapy for complete heart block.1 Ake Senning implanted the first pacemaker as an asynchronous ventricular device2 in 1959. The indications for cardiac pacing therapy have been expanding to include patients with different heart rhythm disorders, including sinus node dysfunction, atrial tachyarrhythmias and heart failure with cardiac dyssynchrony.3–5
No takes yet. Share an insight, caveat, or question.
Ngai‐Yin Chan (2007) conducted a review in Heart rhythm disorders. Cardiac pacing device implantation was evaluated. Cardiac pacing therapy indications have expanded since 1958 to include sinus node dysfunction, atrial tachyarrhythmias, and heart failure with cardiac dyssynchrony.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: